3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Ovarian Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Colonic Neoplasms
2
Carcinoma
2
Brenner Tumor
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Interventions
venetoclax
14
ibrutinib
11
Rituximab
9
obinutuzumab
8
Specimen Handling
7
Cyclophosphamide
7
acalabrutinib
6
Biopsy
6
zanubrutinib
5
pirtobrutinib
5
fludarabine phosphate
4
Lenalidomide
4
ARQ531
4
idelalisib
3
Whole-Body Irradiation
3
Magnetic Resonance Spectroscopy
3
Cyclosporine
3
fludarabine
2
Vincristine
2
Sirolimus
2
Prednisone
2
Mycophenolic Acid
2
Doxorubicin
2
CT-P10
2
Bendamustine Hydrochloride
2
treosulfan
1
tocilizumab
1
pembrolizumab
1
mirdametinib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Disulfides
×
30 days
×
Clear all
No trials found.